Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Finance Online.
Press releases published on March 6, 2025

New study links sports gambling with alcohol-related risks over time
Las Vegas, NV 89109, March 06, 2025 (GLOBE NEWSWIRE) -- A new longitudinal study published in JAMA Psychiatry finds that sports gambling frequency and alcohol-related problems are strongly associated over time, reinforcing concerns about the potential …

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update
- Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase 1a clinical data to be presented in 1H 2025 - - CX-801 (PROBODY® Interferon-alpha 2b) Phase 1a translational …

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Fourth Quarter Gross Profit Margin of 50.2%, up 140 basis points from 48.8% in the third quarter of 2024 Full Year 2024 Net Cash provided by continuing …

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results
– Enrollment completed in VIRAGE Phase 2b clinical trial of VCN-01 in metastatic pancreatic ductal adenocarcinoma (PDAC); topline data expected in Q2 2025 – – VCN-01 development bolstered by FDA award of Fast Track designation for the treatment of PDAC and …

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to March 9, 2025
New York, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on March 6, 2025, it caused to be deposited $60,000 …

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
ORKA-001, targeting IL-23p19, Phase 1 trial ongoing, with pharmacokinetic (PK) data expected in 2H 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout in 2H 2026 that provides multiple opportunities to show differentiation over …

Hummingbird Resources PLC Files Early Warning Report
LONDON, March 06, 2025 (GLOBE NEWSWIRE) -- Hummingbird Resources PLC (“Hummingbird”), a West African gold mining company, announced today that in connection with the implementation of a take-over of Hummingbird pursuant to the UK Takeover Code (the “Code …

Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
First-in-class oral selective SMARCA2 (BRM) inhibitor FHD-909 (LY4050784) continues enrollment in Phase 1 trial for SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population FHD-909 preclinical combination …

Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Full Year 2024 Net Loss of $48.8 Million Compared to Net Loss of $65.1 Million in 2023 Full Year 2024 Adjusted EBITDA of $46.2 Million Compared to $40.8 Million in 2023 Increased Quarterly and Annual Operational Cash Flow Compared to Prior Periods to $7.2 …

Barnes & Noble Education Strengthens Leadership Team with the Appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer
BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Barnes …

NextCure Provides Business Update and Reports Full Year 2024 Financial Results
Completed cohort 1 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers in February 2025 and plan to initiate backfill cohorts in the second half of 2025 Cash of approximately $68.6 million expected to fund operations into the second half of 2026 …

Five Star Bank Appoints Eric Marks Chief Consumer Banking Officer
WARSAW, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (NASDAQ: FISI), parent company of Five Star Bank (“Five Star” or the “Bank”) and Courier Capital, LLC, announced that Eric W. Marks has joined as Senior Vice President, Chief …

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
– Overall BioEnvelope sales up 18%, with same-center sales increasing 65% following EluPro commercialization – SILVER SPRING, Md., March 06, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting …

El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2024 Financial Results
COSTA MESA, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13- and 52-week periods ended December 25, 2024. Highlights for the fourth quarter ended December 25, 2024 compared …

Fidus Investment Corporation Announces Fourth Quarter and Full Year 2024 Financial Results
Board of Directors Declared Total Dividends of $0.54 per Share for First Quarter 2025 Base Dividend of $0.43 and Supplemental Dividend of $0.11 Per Share EVANSTON, Ill, March 06, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” …

Hudson Technologies Reports Fourth Quarter and Year End 2024 Results
Strong unlevered balance sheet with $70.1 million in cash and no debt Repurchased $8.1 million of common stock in 2024 Increased refrigerant reclamation volume by 18% in 2024 WOODCLIFF LAKE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc …

Noodles & Company Announces Fourth Quarter and Full Year 2024 Financial Results
BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Noodles …

FormFactor Partners with Delft Circuits to Revolutionize Quantum Computing Interfacing
LIVERMORE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leader in precision test and measurement solutions, and Delft Circuits, an innovator in high-density cryogenic cabling solutions, have teamed up to integrate Delft …

Reliance Global Group Reports 2024 Results and Provides Business Update
LAKEWOOD, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today provided a business update and reported financial results for the year ended December 31, 2024. “We are pleased to …

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Program for Hepatitis C Virus (HCV) Patient Enrollment in Global Phase 3 HCV Program Expected to Start in April 2025 Conference Call at 4:30 pm ET Today BOSTON, March 06, 2025 (GLOBE …